My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Celldex Therapeutics, Inc. - Common Stock (NQ:CLDX)

25.14 +1.42 (+5.99%)

Streaming Delayed Price Updated: 12:19 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Celldex Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2021 ↗

July 22, 2021

Upgrades According to Stephens & Co., the prior rating for World Acceptance Corp (NASDAQ:...

Via Benzinga

Celldex Therapeutics Raises $250M Via Equity To Support Development Of Skin Disease Candidate ↗

July 14, 2021

Celldex Therapeutics Inc (NASDAQ: CLDX) has priced an underwritten public offering of around 5.9 million shares at $42.00 per share, representing a discount of about 6...

Via Benzinga

Why Celldex Therapeutics Stock Is Jumping Again Today ↗

July 13, 2021

The company announced a public stock offering.

Via The Motley Fool

You Should Know About Monday's 2 Big Nasdaq Winners ↗

July 12, 2021

One's a well-known name, while the other has plenty of potential.

Via The Motley Fool

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump ↗

July 12, 2021

Toward the end of trading Monday, the Dow traded up 0.34% to 34,987.02 while the NASDAQ rose 0.08% to 14,713.30. The S&P also rose, gaining 0.26% to 4,380.72. The U.S. has the...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Dennis Dick On Virgin Galactic's Stock: 'What Do We Have To Look Forward To?' ↗

July 12, 2021

On Monday’s PreMarket Prep, Dennis Dick, and Spencer Israel discussed the large gap up in shares of Virgin Galactic Holdings, Inc.

Via Benzinga

58 Biggest Movers From Yesterday ↗

July 13, 2021

Gainers MediaCo Holding Inc. (NASDAQ: MDIA) shares jumped 311.6% to close at $17.00 on Monday after jumping 20% on Friday. State Auto Financial Corporation (NASDAQ: STFC) shares...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 12, 2021

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock increased by 21.35% to $39.33 during Monday's regular session. Celldex Therapeutics's stock is trading at a volume...

Via Benzinga

Mid-Day Market Update: Crude Oil Down 1%; Celldex Therapeutics Shares Spike Higher ↗

July 12, 2021

Midway through trading Monday, the Dow traded up 0.28% to 34,967.12 while the NASDAQ rose 0.08% to 14,714.09. The S&P also rose, gaining 0.23% to 4,379.69. The U.S. has the...

Via Benzinga

Topics Stocks

38 Stocks Moving In Monday's Mid-Day Session ↗

July 12, 2021

Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in...

Via Benzinga

Why Celldex Therapeutics Stock Is Skyrocketing Today ↗

July 12, 2021

Investors liked Celldex's early stage clinical results.

Via The Motley Fool

Celldex Therapeutics Stock Rocketed Above A Profit-Taking Zone — Here's Why ↗

July 12, 2021

Celldex Therapeutics unveiled bullish test results for its hives treatment on Friday, and CLDX stock flew to a three-year high on Monday.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 12, 2021

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

July 12, 2021

RBC Capital boosted Chipotle Mexican Grill, Inc. (NYSE:C...

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

July 12, 2021

Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL)...

Via Benzinga

Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159 ↗

July 12, 2021

Celldex Therapeutics Inc (NASDAQ: CLDX) got a boost Friday with a data readout from Phase 1b trial of CDX-0159 in patients with antihistamine refractory cold...

Via Benzinga

The Most Volatile Stocks on Earnings — July 2021 ↗

July 09, 2021

The Q2 2021 earnings reporting period starts up next week with five of the six major banks reporting their quarterly numbers.

Via Talk Markets

Top Picks Mid-Year Updates- Celldex Therapeutics ↗

July 04, 2021

Celldex Therapeutics (CLDX) remains one of our Top Picks for 2021 with the company delivering value creating data updates so far this year. The stock has risen 53% so far this year.

Via Talk Markets

Could Celldex Be a Millionaire-Maker Stock? ↗

April 10, 2021

Not at its present valuation, it's not.

Via The Motley Fool

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 29, 2021

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...

Via Benzinga

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition